DE69717301D1 - Verwendung von wachstumshormone - Google Patents
Verwendung von wachstumshormoneInfo
- Publication number
- DE69717301D1 DE69717301D1 DE69717301T DE69717301T DE69717301D1 DE 69717301 D1 DE69717301 D1 DE 69717301D1 DE 69717301 T DE69717301 T DE 69717301T DE 69717301 T DE69717301 T DE 69717301T DE 69717301 D1 DE69717301 D1 DE 69717301D1
- Authority
- DE
- Germany
- Prior art keywords
- growth hormone
- medicament
- treatment
- individuals
- metabolic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9601397A SE9601397D0 (sv) | 1996-04-12 | 1996-04-12 | Use of growth hormone |
PCT/SE1997/000601 WO1997038709A1 (en) | 1996-04-12 | 1997-04-10 | Use of growth hormone |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69717301D1 true DE69717301D1 (de) | 2003-01-02 |
DE69717301T2 DE69717301T2 (de) | 2003-09-04 |
Family
ID=20402176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69717301T Expired - Fee Related DE69717301T2 (de) | 1996-04-12 | 1997-04-10 | Verwendung von wachstumshormone |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0935469B1 (de) |
JP (1) | JP2000510451A (de) |
AT (1) | ATE228007T1 (de) |
CA (1) | CA2250907A1 (de) |
DE (1) | DE69717301T2 (de) |
DK (1) | DK0935469T3 (de) |
ES (1) | ES2187771T3 (de) |
NZ (1) | NZ332105A (de) |
PT (1) | PT935469E (de) |
SE (1) | SE9601397D0 (de) |
WO (1) | WO1997038709A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6087090A (en) * | 1997-02-25 | 2000-07-11 | Celtrix Pharmaceuticals, Inc. | Methods for predicting drug response |
AU737065B2 (en) * | 1997-07-04 | 2001-08-09 | Pharmacia Ab | Use of growth hormone in compositions for treating insulin resistance in the heart and for enhancing protein kinase B (PKB) activity |
CA2352316A1 (en) * | 1998-11-26 | 2000-06-02 | Auckland Uniservices Limited | Treatment of hypertension |
TW514510B (en) | 1999-06-11 | 2002-12-21 | Tanita Seisakusho Kk | Method and apparatus for measuring distribution of body fat |
AU1130501A (en) * | 1999-11-03 | 2001-05-14 | Novo Nordisk A/S | Use of a growth hormone or a growth hormone secretagogue for appetite-suppression or induction of satiety |
SE0000837D0 (sv) | 2000-03-13 | 2000-03-13 | Pharmacia & Upjohn Ab | New use |
AU2006200127B2 (en) * | 2000-03-13 | 2007-10-25 | Pfizer Inc. | Use of growth hormone in low dose |
ATE446758T1 (de) | 2000-05-31 | 2009-11-15 | Pfizer Prod Inc | Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts |
US20040248788A1 (en) * | 2001-07-06 | 2004-12-09 | Vickers Mark Hedley | Hypertenson treatment |
US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
US7833964B2 (en) | 2003-08-21 | 2010-11-16 | Tercica, Inc. | Methods of reducing visceral fat by increasing levels of insulin-like growth factor-I (IGF-I) |
US8440695B2 (en) * | 2005-11-09 | 2013-05-14 | St Jude Children's Research Hospital | Use of chloroquine to treat metabolic syndrome |
CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
EP2118080B1 (de) | 2007-02-09 | 2016-08-31 | Ocera Therapeutics, Inc. | Makrocyclische ghrelin-rezeptormodulatoren und verwendungsverfahren dafür |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5268277A (en) * | 1987-08-07 | 1993-12-07 | Eniricerche S.P.A. | Method for the preparation of human growth hormone |
-
1996
- 1996-04-12 SE SE9601397A patent/SE9601397D0/xx unknown
-
1997
- 1997-04-10 AT AT97919856T patent/ATE228007T1/de not_active IP Right Cessation
- 1997-04-10 WO PCT/SE1997/000601 patent/WO1997038709A1/en active IP Right Grant
- 1997-04-10 EP EP97919856A patent/EP0935469B1/de not_active Expired - Lifetime
- 1997-04-10 CA CA002250907A patent/CA2250907A1/en not_active Abandoned
- 1997-04-10 ES ES97919856T patent/ES2187771T3/es not_active Expired - Lifetime
- 1997-04-10 NZ NZ332105A patent/NZ332105A/xx unknown
- 1997-04-10 DK DK97919856T patent/DK0935469T3/da active
- 1997-04-10 PT PT97919856T patent/PT935469E/pt unknown
- 1997-04-10 JP JP09537020A patent/JP2000510451A/ja active Pending
- 1997-04-10 DE DE69717301T patent/DE69717301T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0935469B1 (de) | 2002-11-20 |
JP2000510451A (ja) | 2000-08-15 |
DE69717301T2 (de) | 2003-09-04 |
DK0935469T3 (da) | 2003-03-17 |
WO1997038709A1 (en) | 1997-10-23 |
PT935469E (pt) | 2003-03-31 |
EP0935469A1 (de) | 1999-08-18 |
SE9601397D0 (sv) | 1996-04-12 |
NZ332105A (en) | 2000-03-27 |
ES2187771T3 (es) | 2003-06-16 |
ATE228007T1 (de) | 2002-12-15 |
CA2250907A1 (en) | 1997-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE228007T1 (de) | Verwendung von wachstumshormone | |
DE69809558D1 (de) | Auswahlmethode für potentielle mittel gegen fettleibigkeit, zur regulierung des ucp-2 | |
Blair et al. | Sustained compression and healing of chronic venous ulcers. | |
Poirier et al. | Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients | |
EP0766966A3 (de) | Methode zur Behandlung der Insulinresistenz | |
Thivel et al. | Surgical weight loss: impact on energy expenditure | |
EA200000747A1 (ru) | СПОСОБ ВВЕДЕНИЯ AspB28-ИНСУЛИНА ЧЕЛОВЕКА | |
SE9201573D0 (sv) | Use of igf-1 | |
UA83854C2 (uk) | Застосування телмісартану для підвищення чутливості до інсуліну | |
CA2196174A1 (en) | Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes | |
ATE290863T1 (de) | Verwendung von prolactinmodulatoren und diät zur herstellung eines medikamentes zur behandlung der fettleibigkeit | |
WO2002070546A3 (en) | Modified derivatives of cck-8 | |
Ampudia-Blasco et al. | A new case of lipoatrophy with lispro insulin in insulin pump therapy: is there any insulin preparation free of complications? | |
Milani et al. | Acute compartment syndrome of the arm after minor trauma in a patient with optimal range of oral anticoagulant therapy: a case report | |
ES2166406T3 (es) | Uso de derivados de 1,5-benzodiazepina para el control del vaciado gastrico en pacientes con diabetes mellitus no dependiente de insulina. | |
DE69728654D1 (de) | Verwendung von il-7 zur behandlung von autoimmunkrankheiten, insbesondere insulinabhängigem diabetes mellitus | |
Pick et al. | The epidemiology of hypertension family practice in Cape Town | |
DK1697401T3 (da) | Tetrapeptid, som regulerer blodglucoseniveauet ved diabetes mellitus | |
ATE209042T1 (de) | Verwendung des wachstumshormons in mitteln zur behandlung der insulinresistenz im herzen | |
Hulbert et al. | The management of paracetamol overdose by junior doctors. | |
Holst et al. | Diurnal profile of pancreatic polypeptide and gut glucagon in human morbid obesity | |
Tibrewal et al. | Is day surgery for Wilson's osteotomy safe? | |
TH23897A (th) | โปรตีนต้านความอ้วน | |
TH23897B (th) | โปรตีนต้านความอ้วน | |
Marris | TAHYCARDIA: OBSERVATIONS UPON ITS OCCURRENCE IN THE ENTERIC AND OTHER FEVERS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |